[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
CIBR: Center for Innovative Biomedical Resources
  • TGL-Banner-NEW
  • Genomics-banner01
Translational Genomics Laboratory

TGL Test Descriptions

Suggestion Box

Satisfaction Survey

Download Brochure

TGL-side

CONTACT:

Parvez M. Lokhandwala, MBBS, MSc, PhD

Parvez M. Lokhandwala, MBBS, MSc, PhD

Laboratory Director of Translational Genomics Laboratory
Associate Director, Blood Bank and Transfusion Medicine
Associate Medical Director of Blood Bank & Transfusion Service;
Medical Director of Tissue Bank; Associate Program Director, Pathology Residency Program
PLokhandwala@som.umaryland.edu

Nick Ambulos

Nicholas P. Ambulos, PhD

Director, Genomics Core Facility
nambulos@som.umaryland.edu 

Danielle Sewell, BS

Danielle Sewell, MSRS

Compliance Manager

410-706-3339

LOCATION:

Room 7-037
Bressler Research Building
655 West Baltimore Street
Baltimore, MD 21201

HOURS:

Monday through Friday,
8:00am - 5:00pm

PHONE

Lab: 410-706-3339
Fax: 410-706-0287

MISSION

The mission of the TranslationalGenomics Laboratory (TGL) is to provide a critical bridge to help accelerate translation from discovery into precision health care, by providing DNA sequencing, genotyping and array-based technologies in both a basic research and clinically-regulated environment.

ABOUT THE TGL

The Translational Genomics Laboratory (TGL) is the result of 35 years of core facility evolution, starting with peptide and oligonucleotide synthesis, to the current CAP (College of American Pathologists) accredited and CLIA (Clinical Laboratory Improvement Amendments) compliant laboratory, capable of providing support to clinical and translational genetic/genomics studies (CAP# 8017554; CLIA# 21D2027356).

TGL is part of the University of Maryland School of Medicine’s Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCC), the Program for Personalized and Genomic Medicine (PPGM), and the Center for Innovative Biomedical Resources (CIBR).

The services offered by the TGL support basic research. The clinical assays offered are similar to those offered to support basic research, except that these assays are validated under CLIA, enabling them to be used in the clinical decision-making process in research protocols and for routine patient care.

TGL-03SERVICES

Clinical

Basic Research

  • Cytogenomic Arrays
  • Extraction of Nucleic Acid
    • DNA
    • RNA
  • Gene Expression Arrays
    • Global Expression Profiling
    • miRNA Expression Profiling
    • Transcriptome Analysis
  • Genotyping
    • Taqman Assays
  • Next Generation Sequencing (NGS) Gene Panels
  • Sanger DNA Sequencing

TGL-02

Instrumentation

  • Applied Biosystems 3730XL (Sanger sequencing)
  • Affymetrix GeneChip system 3000 7G (chip-based arrays, e.g. CytoScan HD, DMET)
  • Applied Biosystems 9700 thermocycler (PCR amplification)
  • Nanodrop single-channel and 8-channel spectrophotometers
  • ThermoFisher QuantStudio 5
  • Thermofisher Ion Chef System
  • Thermofisher Ion S5 Sequencer

TGL02

FORMS & DOCUMENTS

CAP Accreditation Certificate

CLIA Certificate of Accreditation 2024 to 2026

Medical Laboratory Permit

QA-506 Clinical Services Test Requisition

QA-514 Clinical Services Test Requisition Extract and Hold Only

TGL-image03

TGL-04